OAM
RCKT icon

Oxford Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Oxford Asset Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-54,801
Closed -$134K – 680
2025
Q2 		$134K Buy
54,801
+42,492
+345% +$215K 0.04% 459
2025
Q1 		$82.1K Buy
+12,309
New +$122K 0.04% 432
2018
Q3 		– Sell
-17,303
Closed -$334K – 1887
2018
Q2 		$334K Sell
17,303
-29,078
-63% -$550K 0.01% 1467
2018
Q1 		$870K Buy
+46,381
New +$756K 0.02% 999
2017
Q1 		– Sell
-25,298
Closed -$617K – 1463
2016
Q4 		$617K Buy
+25,298
New +$722K 0.02% 557
2016
Q3 		– Sell
-3,975
Closed -$118K – 840
2016
Q2 		$118K Buy
+3,975
New +$140K ﹤0.01% 727
2016
Q1 		– Sell
-2,519
Closed -$115K – 880
2015
Q4 		$115K Buy
+2,519
New +$110K ﹤0.01% 830

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $315M AUM 54.4% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return